Visualizing Updates in Melanoma Management: Novel Combinations, Development, and Best Practices in Sequencing Therapy
July 17, 2023
July 17, 2024
This activity is provided by Med Learning Group.
This activity is co-provided by AMEDCO
Nursing learners, view this Learner Notification prior to starting this activity
This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc..
- Physicians - maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses - 1.0 Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
This activity is designed to meet the educational needs of oncologists, nurse practitioners, oncology pharmacists, and physician assistants to ensure confidence in the management of advanced melanoma.
This educational virtual pathways program will help healthcare providers to optimize immunopathological assessment of melanoma, particularly in consideration of patterns of resistance. Specifically, the programming will improve clinicians’ knowledge of the latest data on combination therapies in advanced melanoma across settings of care, while preparing them to manage adverse events with these combination therapies for advanced melanoma.
Upon completion of this program, participants should be able to:
- Summarize current considerations in the immunopathological assessment of melanoma, particularly in consideration of patterns of resistance
- Recognize the latest updates considering combination therapies in advanced melanoma across settings of care
- Evaluate current data in consideration of potential adverse events with combination therapeutic approaches in melanoma
Adil Daud, MD
Clinical Professor, Department of Medicine (Hematology/Oncology), UCSF
Director, Melanoma Clinical Research
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Physician Credit Designation Statement
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™ Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team
Nursing Continuing Education Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure of Relevant Financial Relationships
- Adil Daud, MD
- Consulting fees: Genoptix, GlaxoSmithKline, OncoSec Medical, Caris Life Sciences, Eisai, and GLG
- Contracted research: Bristol Myers Squibb, Checkmate Pharmaceuticals, Genentech/Roche (Inst), GlaxoSmithKline (Inst), Incyte, and Merck/Schering-Plough
- Patents: OncoSec Medical, TRexBio, and UCSF
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed. The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer. The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they partner have with ineligible companies related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Vaidehee Deshpande, PHD, Medical Director for Med Learning Group, has nothing to disclose.
Lisa Crenshaw, Program Manager for Med Learning Group, has nothing to disclose.
Morgan Kravarik, Associate Program Manager for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
Method of Participation
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
- Read the CME/CNE information and faculty disclosures.
- Participate in the enduring activity.
- Complete the online post-test and evaluation
You will receive your certificate as a downloadable file.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at email@example.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: https://www.medlearninggroup.com/privacy-policy/
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at firstname.lastname@example.org
Content - Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.